Nifedipine Tablet, Extended Release
Product Images NDC 70518-3520

NIFEdipine is a prescription medication in the form of an extended-release tablet. Each tablet contains 60mg of the active ingredient. Patients should swallow the tablet whole and avoid chewing or crushing it. It is an IR medication, and a prescription is required to purchase it. The NDC number is 70518-3520-00, and the LOT number and expiration date are missing from the text. The manufacturer is listed as Ingenus and the repackager as RemedyRepack Inc. The medication should be stored in temperatures ranging from 15-30°C (59-86°F) with excursions permitted up to 20-25°C (88-77°F). The package insert should be followed for directions for use.*

This is a chart that compares side effects reported by patients taking Nifedipine extended-release tablets versus a placebo. The side effects include headache, fatigue, dizziness, constipation, and nausea. The percentage of patients experiencing each adverse effect is listed for both Nifedipine and Placebo groups.*

This is a table showing the percentage of adverse effects experienced by participants taking Nifedipine Capsules and a placebo. The table is divided into two columns: one for the percentage of participants who experienced a particular adverse effect while taking Nifedipine Capsules, and another column showing the percentage of those who experienced the same effect while taking a placebo. The adverse effects listed include dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat.*